🇮🇹 SUGEMALIMAB in Italy

SUGEMALIMAB (SUGEMALIMAB) regulatory status in Italy.

Marketing authorisation

AIFA

  • Local brand name: Cejemly
  • Status: approved

SUGEMALIMAB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Italy

Frequently asked questions

Is SUGEMALIMAB approved in Italy?

Yes. AIFA has authorised it.

Who is the marketing authorisation holder for SUGEMALIMAB in Italy?

Marketing authorisation holder not available in our data.